Home>>30C-NBOMe (hydrochloride)

30C-NBOMe (hydrochloride)

Catalog No.GC42243

25C-NBOMe (hydrochloride) is a derivate of the 2,5-dimethoxy phenethylamine hallucinogen 2C-C.

Products are for research use only. Not for human use. We do not sell to patients.

30C-NBOMe (hydrochloride) Chemical Structure

Size Price Stock Qty
1mg
$43.00
In stock
5mg
$117.00
In stock
10mg
$163.00
In stock
50mg
$472.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

25C-NBOMe (hydrochloride) is a derivate of the 2,5-dimethoxy phenethylamine hallucinogen 2C-C . The N-(2-methoxybenzyl) addition at the amine of 2C-C, to give 25C-NBOMe, increases affinity and selectivity for the 5-HT2A receptor over other serotonin receptors. [1] 30C-NBOMe is an analog of 25C-NBOMe having methoxy groups at the three, four, and five positions, rather than the two position, on the benzene ring. While the 3,4,5-trimethoxybenzyl structure is like that found in the psychedelic alkaloid mescaline , this compound has a shortened chain length. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research purposes.

Reference:
[1]. Braden, M.R., Parrish, J.C., Naylor, J.C., et al. Molecular interaction of serotonin 5-HT2A receptor residues Phe3396.51 and Phe3406.52 with superpotent N-benzyl phenethylamine agonists. Mol. Pharm. 70(6), 1956-1965 (2006).

Reviews

Review for 30C-NBOMe (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 30C-NBOMe (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.